4735-50-6

Basic information

• Product Name: 1-NaphthaleneethanaMine HCl
• Synonyms: 1-NaphthaleneethanaMine HCl
• CAS NO: 4735-50-6
• Molecular Formula: C₁₂H₁₃N
• Molecular Weight: 207.69926
• Mol File: 4735-50-6.mol
• Article Data: 1

Chemical Properties

• Melting Point: 212-213 °C (decomp)
• Boiling Point: 313.9°Cat760mmHg
• Flash Point: 153°C
• Appearance: /
• Density: 1.069g/cm³
• PKA: 9.78±0.10(Predicted)
• CAS DataBase Reference: 1-NaphthaleneethanaMine HCl(CAS DataBase Reference)
• NIST Chemistry Reference: 1-NaphthaleneethanaMine HCl(4735-50-6)
• EPA Substance Registry System: 1-NaphthaleneethanaMine HCl(4735-50-6)

Safety Data

• Hazardous Substances Data: 4735-50-6(Hazardous Substances Data)

Usage

General Description

1-NaphthaleneethanaMine HCl, also known as Naphazoline hydrochloride, is a pharmaceutical drug used as a decongestant and vasoconstrictor. It works by narrowing the blood vessels in the nasal passages, which helps to relieve congestion and alleviate symptoms of a stuffy nose caused by allergies, hay fever, or the common cold. This chemical is commonly found in over-the-counter nasal sprays and eye drops, and its vasoconstrictive properties make it effective in reducing swelling and redness in the eyes. While generally safe for short-term use, prolonged or excessive use of products containing 1-NaphthaleneethanaMine HCl can lead to side effects such as rebound congestion, dizziness, and increased blood pressure. It is important to use this chemical as directed by a healthcare professional to minimize the risk of adverse effects.

Downstream Products

• 3185-51-1 N-(2-[1]naphthyl-ethyl)-benzamide 
• 1026366-16-4 [1-{[2-(tert-Butyl-dimethyl-silanyloxy)-3,3,3-trifluoro-1-isopropyl-propylcarbamoyl]-methyl}-4-(2-naphthalen-1-yl-ethylcarbamoyl)-2-oxo-1,2-dihydro-pyridin-3-yl]-carbamic acid benzyl ester 
• 406953-53-5 [1-(S)-[4-nitroguanidino-1-(2-naphthalen-1-yl-ethylcarbamoyl)-butylcarbamoyl]-2-(R)-phenyl-ethyl]-carbamic acid tert-butyl ester 
• 20062-23-1 N-[2-(2-(naphthalen-1-yl)ethyl)]isoindoline-1,3-dione 
• 1394122-22-5 C₃₂H₃₇FN₈O₃S 
• 1365477-69-5 C₂₇H₃₀N₂O₅ 
• 229-67-4 benzo[f]isoquinoline 
• 86977-96-0 (2S,2aR)-2a-Methylsulfanyl-2-((3R,4S)-2-oxo-3-phenoxy-4-phenyl-azetidin-1-yl)-2,2a,9,10-tetrahydro-10a-aza-cyclobuta[a]phenanthren-1-one 
• 86977-97-1 (2S,2aR)-2-((3S,4R)-2-Oxo-3-phenoxy-4-phenyl-azetidin-1-yl)-2,2a,9,10-tetrahydro-10a-aza-cyclobuta[a]phenanthren-1-one 
• 86977-89-1 13-Aza-3-deoxy-14-methylthio-15-phenoxyacetamido-16-norequilenin 
• 86977-91-5 13-Aza-3-deoxy-15-phenoxyacetamido-16-norequilenin 
• 86977-86-8 13-Aza-3-deoxy-14-methylthio-15-phenoxy-16-norequilenin 
• 86977-90-4 13-Aza-3-deoxy-15-phenoxy-16-norequilenin 
• 98977-58-3 (E)-N-methyl-N-(3-phenyl-2-propenyl)-1-naphthalene-2-ethanamine 

Relevant articles and documents

Novel compounds and compositions for treating diseases asociated with protease activity

Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.